PharmaceuticalfirmAstrazenecaannouncedthepauseofthetrialWednesday,afteroneoftheBritishparticipantsfellillreportedlywithtransversemyelitis.Inflammationofthespinalcord,theparticipantisexpectedtorecover.ThecoronavirusvaccinedevelopedbyAstrazenecaandoxforduniversity,isseenasoneofthemostpromisingofdozensunderdevelopmentaroundtheworld.Aftersuccessfulearlystagetrials,ithadmovedtophase3testinginrecentweeks,involving30,participantsintheUnitedStates,Britain,BrazilandSouthAfrica.Scientistsemphasizedthatthereisnoindicationyetthattheparticipantsillnessislinkedtothevaccine.Youregivingthevaccinetoverylargenumbersofpeople.Andatanygiventimerandomlybychance,itsquitepossiblesomeofthoseparticipantsmayhavehealthproblemsthathappento

转载请注明:http://www.gvccw.com//mjcczl/14001.html